WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
600853 Long Jian Road & Bridge
- 3.82
- +0.07+1.87%
Market Closed Apr 3 15:00 CST
3.87BMarket Cap9.39P/E (TTM)
3.83High3.70Low252.13KlotVolume3.71Open3.75Pre Close95.57MTurnover2.49%Turnover Ratio9.39P/E (Static)1.01BShares5.1052wk High1.21P/B3.86BFloat Cap2.9052wk Low4.13Limit Up1.01BShs Float8.14Historical High3.38Limit Down3.47%Amplitude0.32Historical Low0.04Dividend TTM3.79Avg Price98.47KlotAsk0.92%Div YieldTTM100Lot Size146.28KlotBid
Long Jian Road & Bridge Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 33.94%5.67B | 5.80%3.73B | 13.05%3.9B | -13.42%3.49B | -33.51%4.23B | -9.79%3.52B | -29.46%3.45B | -18.24%4.03B | 18.76%6.37B | -4.47%3.9B |
| Transactional financial assets | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M |
| Notes receivable and accounts receivable | 1.23%9.5B | 20.90%6.89B | 22.31%6.45B | 50.35%7.77B | 59.81%9.39B | 36.29%5.7B | 33.82%5.27B | 43.21%5.17B | 46.43%5.87B | 13.43%4.18B |
| -Notes receivable | -81.07%2.39M | -89.50%1.66M | -84.99%3.28M | -42.84%5.94M | 9.58%12.64M | 139.75%15.82M | 1,518.05%21.84M | -79.09%10.4M | 433.54%11.54M | 45.34%6.6M |
| -Accounts receivable | 1.34%9.5B | 21.20%6.89B | 22.76%6.45B | 50.54%7.77B | 59.91%9.37B | 36.12%5.69B | 33.31%5.25B | 44.91%5.16B | 46.23%5.86B | 13.40%4.18B |
| Other receivables (including interest and dividends) | 18.17%718.93M | 12.39%796.51M | 9.79%768.54M | 7.74%758.09M | -5.52%608.38M | -2.00%708.69M | 7.59%699.99M | 3.84%703.63M | 13.93%643.95M | 27.40%723.16M |
| -Other receivable | ---- | ---- | 9.79%768.54M | ---- | -5.52%608.38M | ---- | 7.59%699.99M | ---- | 13.93%643.95M | ---- |
| Contractual assets | 8.91%3.66B | 40.25%5.53B | 36.79%4.88B | 18.76%3.64B | 20.51%3.36B | -7.22%3.94B | 12.58%3.57B | -2.16%3.07B | 6.30%2.79B | 7.05%4.25B |
| Advance payment | -98.24%4.06M | -60.35%381.64M | -45.28%402.09M | -80.38%322.43M | -69.54%230.65M | -25.19%962.45M | -43.25%734.77M | 43.84%1.64B | 83.13%757.12M | 406.46%1.29B |
| Inventories | 21.82%1.69B | -15.80%1.4B | -24.95%1.59B | -23.06%1.52B | 10.81%1.39B | 11.09%1.66B | 21.20%2.12B | 12.87%1.98B | -29.68%1.25B | -4.21%1.49B |
| Non-current assets due within one year | -30.52%75.83M | -34.85%75.83M | -71.55%75.83M | -52.34%127.05M | -55.40%109.15M | -50.22%116.4M | 160.69%266.54M | 9.65%266.54M | 9.98%244.75M | -7.56%233.83M |
| Other current assets | -4.80%1.01B | 7.43%1.06B | -0.79%1.08B | 8.51%1.1B | 16.78%1.06B | 17.58%986.41M | 50.72%1.09B | 9.21%1.01B | 18.60%910.18M | 50.95%838.95M |
| Total current assets | 9.55%22.42B | 12.78%19.94B | 11.26%19.23B | 4.80%18.82B | 8.15%20.46B | 4.04%17.68B | 4.10%17.29B | 8.81%17.96B | 19.53%18.92B | 13.18%16.99B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%183.7M | 44.74%183.7M | 44.74%183.7M | 44.74%183.7M | 44.98%183.7M | 0.17%126.92M | 65.87%126.92M | 434.79%126.92M | 433.90%126.71M | 377.02%126.71M |
| Long-term equity investment | 16.69%1.43B | 36.75%1.41B | 51.54%1.37B | 49.02%1.31B | 42.15%1.22B | 69.20%1.03B | 49.45%902.96M | 55.54%879.65M | 62.58%861.4M | 20.02%607.49M |
| Long term receivable account | -15.37%69.74M | -16.62%64.7M | -16.87%64.51M | -16.87%64.51M | -13.11%82.4M | --77.59M | -57.77%77.59M | -57.77%77.59M | -45.55%94.84M | ---- |
| Fixed assets | ---- | ---- | --949.28M | ---- | 13.16%926.74M | ---- | ---- | ---- | 4.52%818.93M | ---- |
| Constru in process | ---- | ---- | --11.74M | ---- | -85.29%10.79M | ---- | ---- | ---- | 19.00%73.32M | ---- |
| Productive biological assets | -39.46%1.34M | -25.78%2.46M | -33.33%2.21M | -33.33%2.21M | -33.33%2.21M | -25.00%3.31M | -25.00%3.31M | -25.00%3.31M | -25.00%3.31M | -20.00%4.41M |
| Intangible assets | -2.63%1.88B | -15.65%1.89B | -14.00%1.92B | -13.65%1.92B | -13.56%1.93B | 3.09%2.24B | 28.36%2.24B | 40.51%2.23B | 41.11%2.23B | 388.67%2.17B |
| Goodwill | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M |
| Long deferred expense | -4.29%47.65M | 16.92%60.5M | -8.79%47.83M | -9.40%49.72M | -12.81%49.78M | 16.33%51.74M | 14.31%52.44M | 12.03%54.88M | 14.08%57.1M | 255.78%44.48M |
| Deferred tax assets | 19.72%61.24M | 31.85%59.6M | 22.37%59.78M | 38.36%49.43M | 29.32%51.15M | 35.17%45.2M | 48.51%48.85M | 19.22%35.73M | 19.25%39.56M | -0.97%33.44M |
| Usufruct assets | 27.43%1.87M | -29.71%1.1M | 6.20%1.22M | -91.86%1.34M | -91.85%1.46M | -95.28%1.57M | -97.50%1.15M | -73.59%16.51M | -72.40%17.97M | -49.25%33.23M |
| Other non current assets | -9.69%10.47B | 6.13%11.28B | 10.08%11.34B | 20.88%11.28B | 25.88%11.6B | 12.57%10.63B | 17.34%10.3B | 22.64%9.33B | 23.55%9.21B | 34.10%9.44B |
| Total non current assets | -5.99%15.1B | 5.40%15.94B | 8.92%15.95B | 16.10%15.83B | 18.63%16.06B | 13.53%15.12B | 18.55%14.65B | 24.46%13.64B | 25.76%13.54B | 43.41%13.32B |
| Total assets | 2.72%37.51B | 9.38%35.87B | 10.19%35.18B | 9.68%34.66B | 12.52%36.52B | 8.21%32.8B | 10.26%31.93B | 15.06%31.6B | 22.05%32.46B | 24.73%30.31B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 3.48%3.17B | 24.83%3.61B | 43.72%3.72B | 54.67%3.7B | 2.33%3.06B | -12.82%2.89B | -22.76%2.59B | -29.25%2.39B | 6.68%2.99B | -6.87%3.32B |
| Notes payable and accounts payable | 4.68%11.83B | 17.79%10.4B | 23.28%9.65B | 20.39%9.3B | 27.53%11.3B | 12.81%8.83B | 13.61%7.83B | 26.37%7.72B | 15.66%8.86B | 7.45%7.83B |
| -Notes payable | -11.87%1.47B | -10.61%1.66B | -2.53%1.67B | -4.84%1.75B | 6.42%1.66B | 8.03%1.85B | 0.37%1.71B | 0.52%1.84B | 11.82%1.56B | 27.49%1.72B |
| -Accounts payable | 7.53%10.36B | 25.34%8.74B | 30.51%7.98B | 28.28%7.55B | 32.05%9.64B | 14.15%6.98B | 17.97%6.12B | 37.42%5.88B | 16.52%7.3B | 2.91%6.11B |
| Contract liabilities | 1.35%2.92B | -20.85%2.13B | -4.67%2.85B | -23.32%2.72B | -19.68%2.88B | 68.04%2.69B | 54.83%2.99B | 64.73%3.55B | 90.31%3.59B | 327.40%1.6B |
| Salaries payable | 17.90%236.68M | 6.92%192.12M | 5.25%183.51M | 20.11%150.83M | 11.08%200.75M | -1.13%179.69M | 12.64%174.35M | -5.10%125.57M | 29.16%180.73M | 11.23%181.74M |
| Taxs payable | 61.04%185.09M | 105.52%84.22M | 54.69%55.33M | 18.62%53.94M | 31.93%114.93M | -41.23%40.98M | -31.54%35.77M | -75.17%45.47M | -21.31%87.12M | 69.81%69.72M |
| Other payable (including interest and dividends) | 0.60%323.76M | -4.56%310.48M | -7.02%326.33M | -22.44%309.23M | -23.01%321.82M | -33.86%325.32M | -16.16%350.98M | -4.25%398.68M | -5.35%417.99M | -1.44%491.87M |
| -Dividend payable | ---- | 0.00%735.72K | 0.00%735.72K | 0.00%735.72K | -53.33%735.72K | 0.00%735.72K | 0.00%735.72K | 0.00%735.72K | 114.27%1.58M | 0.00%735.72K |
| -Other payable | ---- | ---- | --325.6M | ---- | -22.89%321.09M | ---- | ---- | ---- | -5.55%416.42M | ---- |
| Non current liabilities due within one year | -11.22%2.3B | 3.99%2.42B | 29.96%2.84B | 45.62%2.8B | 99.86%2.59B | 50.50%2.33B | 9.92%2.19B | -11.28%1.92B | -18.79%1.3B | -28.82%1.55B |
| Other current liabilities | -9.48%1.42B | 20.71%1.6B | 13.40%1.55B | 31.43%1.55B | 36.96%1.57B | 17.22%1.32B | 33.39%1.37B | 35.41%1.18B | 26.35%1.15B | 36.84%1.13B |
| Total current liabilities | 1.55%22.39B | 11.48%20.75B | 20.87%21.19B | 18.71%20.57B | 18.72%22.05B | 15.12%18.61B | 10.80%17.53B | 12.46%17.33B | 19.44%18.57B | 8.31%16.17B |
| Current liabilities | ||||||||||
| Long term loan | -0.98%8.51B | -4.46%8.87B | -11.56%8.38B | -9.12%8.55B | -3.28%8.6B | 4.76%9.29B | 14.32%9.47B | 20.52%9.41B | 29.56%8.89B | 99.37%8.86B |
| Long term account payable | ---- | ---- | --0 | ---- | --0 | ---- | -19.32%594.56M | ---- | 386.36%484.32M | ---- |
| Specific account payable | ---- | ---- | --220K | ---- | -90.37%2.13M | ---- | ---- | ---- | -64.38%22.13M | ---- |
| Deferred tax liabilities | 27.43%279.8K | --165.38K | --219.58K | --219.58K | --219.58K | ---- | ---- | ---- | ---- | ---- |
| Long term deferred income | -15.13%5.41M | 4.25%6.37M | 9.45%6.37M | 0.31%6.37M | 0.00%6.37M | 5.89%6.11M | -8.63%5.82M | -0.31%6.35M | 0.00%6.37M | -80.56%5.77M |
| Lease liabilities | -25.78%608.58K | -60.88%305.34K | 8.13%850.2K | 13.36%850.2K | 6.87%819.94K | -91.58%780.59K | -91.95%786.29K | -92.28%749.99K | -92.11%767.23K | 46.17%9.27M |
| Total non current liabilities | -1.01%8.52B | -10.37%8.88B | -16.77%8.38B | -13.95%8.56B | -8.46%8.61B | -0.70%9.91B | 11.09%10.07B | 24.57%9.95B | 33.59%9.4B | 91.67%9.98B |
| Total liabilities | 0.83%30.91B | 3.89%29.63B | 7.14%29.57B | 6.80%29.14B | 9.58%30.66B | 9.08%28.52B | 10.90%27.6B | 16.60%27.28B | 23.85%27.97B | 29.87%26.14B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.01%1.01B | -0.01%1.01B | -0.01%1.01B | -0.01%1.01B | 0.00%1.01B | 0.00%1.01B | 0.00%1.01B | 0.00%1.01B | 0.00%1.01B | 1.00%1.01B |
| Other equity instruments | --500M | --500M | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%200M | -61.54%200M |
| -Equity of Perpetual debt | ---- | --500M | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%200M | -61.54%200M |
| Capital reserve funds | 45.57%202.94M | 45.27%186.36M | 39.58%188.36M | 3.27%139.35M | 3.31%139.41M | -1.46%128.28M | 3.65%134.94M | 3.65%134.94M | 3.65%134.94M | 3.42%130.19M |
| Surplus reserve funds | 3.11%72.44M | 4.44%70.26M | 4.44%70.26M | 4.44%70.26M | 4.44%70.26M | 32.89%67.27M | 32.89%67.27M | 32.89%67.27M | 32.89%67.27M | 22.83%50.62M |
| Retained profit | 24.37%1.92B | 23.39%1.74B | 23.96%1.61B | 20.93%1.55B | 23.76%1.54B | 27.48%1.41B | 26.06%1.3B | 30.36%1.28B | 31.37%1.24B | 28.34%1.11B |
| Less:Treasury stock | -1.25%14.52M | -1.25%14.52M | -1.25%14.52M | -1.25%14.52M | 0.00%14.7M | 0.00%14.7M | 0.00%14.7M | 0.00%14.7M | 0.00%14.7M | --14.7M |
| Other composite income | 0.00%-21.93M | 0.00%-21.93M | 0.00%-21.93M | 0.00%-21.93M | 0.00%-21.93M | 29.50%-21.93M | 14.08%-21.93M | 16.89%-21.93M | 0.00%-21.93M | -50.12%-31.1M |
| Specific reserves | 190.57%24.19M | 60.08%43.21M | -11.98%24.59M | -33.78%14.13M | -46.82%8.32M | -21.65%26.99M | 10.60%27.94M | 7.88%21.34M | 20.05%15.66M | -34.78%34.45M |
| Shareholders equity without minority interests | 34.97%3.69B | 34.75%3.52B | 14.53%2.87B | 10.80%2.75B | 3.63%2.74B | 4.83%2.61B | 3.99%2.51B | 5.32%2.48B | 13.85%2.64B | -3.70%2.49B |
| Minority interests | -6.98%2.91B | 63.45%2.73B | 50.35%2.74B | 50.88%2.77B | 70.01%3.13B | -0.40%1.67B | 9.73%1.82B | 7.37%1.84B | 9.31%1.84B | 5.91%1.68B |
| Total shareholder equity | 12.59%6.6B | 45.94%6.25B | 29.62%5.61B | 27.85%5.52B | 30.89%5.87B | 2.73%4.28B | 6.33%4.33B | 6.18%4.32B | 11.94%4.48B | -0.05%4.17B |
| Total liabilityies and equity | 2.72%37.51B | 9.38%35.87B | 10.19%35.18B | 9.68%34.66B | 12.52%36.52B | 8.21%32.8B | 10.26%31.93B | 15.06%31.6B | 22.05%32.46B | 24.73%30.31B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- | -- | -- | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- | -- | -- | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.